KR102523786B1 - 트리아졸로피리딘 화합물의 제조 방법 - Google Patents

트리아졸로피리딘 화합물의 제조 방법 Download PDF

Info

Publication number
KR102523786B1
KR102523786B1 KR1020197015696A KR20197015696A KR102523786B1 KR 102523786 B1 KR102523786 B1 KR 102523786B1 KR 1020197015696 A KR1020197015696 A KR 1020197015696A KR 20197015696 A KR20197015696 A KR 20197015696A KR 102523786 B1 KR102523786 B1 KR 102523786B1
Authority
KR
South Korea
Prior art keywords
compound
salt
acid
formula
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197015696A
Other languages
English (en)
Korean (ko)
Other versions
KR20190085004A (ko
Inventor
후미토 시모마
다카시 야마구치
쇼이치 사가와
Original Assignee
니뽄 다바코 산교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 니뽄 다바코 산교 가부시키가이샤 filed Critical 니뽄 다바코 산교 가부시키가이샤
Publication of KR20190085004A publication Critical patent/KR20190085004A/ko
Application granted granted Critical
Publication of KR102523786B1 publication Critical patent/KR102523786B1/ko
Assigned to 시오노기세야쿠 가부시키가이샤 reassignment 시오노기세야쿠 가부시키가이샤 권리의 전부이전등록 Assignors: 니뽄 다바코 산교 가부시키가이샤
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020197015696A 2016-11-25 2017-11-24 트리아졸로피리딘 화합물의 제조 방법 Active KR102523786B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2016-228897 2016-11-25
JP2016228897 2016-11-25
PCT/JP2017/042239 WO2018097254A1 (ja) 2016-11-25 2017-11-24 トリアゾロピリジン化合物の製造方法

Publications (2)

Publication Number Publication Date
KR20190085004A KR20190085004A (ko) 2019-07-17
KR102523786B1 true KR102523786B1 (ko) 2023-04-20

Family

ID=62195187

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197015696A Active KR102523786B1 (ko) 2016-11-25 2017-11-24 트리아졸로피리딘 화합물의 제조 방법

Country Status (11)

Country Link
US (1) US11434238B2 (https=)
EP (1) EP3546459A4 (https=)
JP (2) JP6600103B2 (https=)
KR (1) KR102523786B1 (https=)
CN (1) CN110214139B (https=)
AU (1) AU2017364725B2 (https=)
CA (1) CA3044654A1 (https=)
IL (1) IL266858B (https=)
MX (1) MX2019006083A (https=)
RU (1) RU2752384C2 (https=)
WO (1) WO2018097254A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019006083A (es) * 2016-11-25 2019-07-10 Japan Tobacco Inc Metodo para la produccion de compuesto de triazolopiridina.
CN113387948B (zh) * 2021-02-06 2022-06-10 成都诺和晟泰生物科技有限公司 一种稠环杂芳基衍生物及其药物组合物和治疗方法及用途
CN115246830A (zh) * 2021-04-28 2022-10-28 广东东阳光药业有限公司 一种酸的固体形式及其制备方法
CN114773333A (zh) * 2021-12-25 2022-07-22 上海泰坦科技股份有限公司 一种卤代三唑并吡啶的合成方法
CN117327066A (zh) * 2022-06-30 2024-01-02 上海济煜医药科技有限公司 一种新多晶型、其制备方法及其用于制备药物的用途
CN117486878A (zh) * 2023-10-27 2024-02-02 扬州市普林斯医药科技有限公司 一种恩那司他的制备方法
CN119039291A (zh) * 2024-09-09 2024-11-29 南京药坦生物科技有限公司 一种恩那度司他中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2455381T1 (sl) * 2009-07-17 2014-08-29 Japan Tobacco Inc. Triazolopiridinova spojina in njeno delovanje kot zaviralec prolil-hidroksilaze in induktor produkcije eritropoietina
US20180243271A1 (en) * 2015-05-28 2018-08-30 Japan Tobacco Inc. Method for Treating or Preventing Diabetic Nephropathy
WO2017083431A2 (en) * 2015-11-09 2017-05-18 Forge Therapeutics, Inc. Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
MX2019006083A (es) * 2016-11-25 2019-07-10 Japan Tobacco Inc Metodo para la produccion de compuesto de triazolopiridina.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of Heterocyclic chemistry, 2008, Vol. 45, No, 5, pp.1451-1456(2009.03.13.) 1부.*

Also Published As

Publication number Publication date
JPWO2018097254A1 (ja) 2019-10-17
RU2019119584A (ru) 2020-12-25
JP2020073474A (ja) 2020-05-14
KR20190085004A (ko) 2019-07-17
IL266858A (en) 2019-08-29
MX2019006083A (es) 2019-07-10
AU2017364725B2 (en) 2021-04-01
IL266858B (en) 2021-10-31
CN110214139B (zh) 2022-08-23
AU2017364725A1 (en) 2019-06-13
EP3546459A1 (en) 2019-10-02
US20200339563A1 (en) 2020-10-29
JP6600103B2 (ja) 2019-10-30
RU2019119584A3 (https=) 2021-03-25
WO2018097254A1 (ja) 2018-05-31
BR112019010017A2 (pt) 2019-08-20
CN110214139A (zh) 2019-09-06
EP3546459A4 (en) 2020-05-20
CA3044654A1 (en) 2018-05-31
US11434238B2 (en) 2022-09-06
RU2752384C2 (ru) 2021-07-26

Similar Documents

Publication Publication Date Title
KR102523786B1 (ko) 트리아졸로피리딘 화합물의 제조 방법
JP6392436B2 (ja) 置換された5−フルオロ−1h−ピラゾロピリジン類を製造するための方法
JP5894531B2 (ja) N−アシルビフェニルアラニンを製造するための方法
WO2016106384A1 (en) Processes for preparing ask1 inhibitors
JP7167171B2 (ja) 4環性化合物の製造方法
HK40011299A (en) Method for producing triazolopyridine compound
JP6797839B2 (ja) テリフルノミドの新規製造方法
BR112019010017B1 (pt) Método para produção de composto de triazolopiridina
EA040460B1 (ru) ПРОТОДЕКАРБОКСИЛИРОВАНИЕ ПРОИЗВОДНЫХ α-ГАЛОГЕНАКРИЛОВОЙ КИСЛОТЫ, КАТАЛИЗИРУЕМОЕ ПЕРЕХОДНЫМ МЕТАЛЛОМ
JP2002105053A (ja) ピリジン化合物の製造方法
JPH10330341A (ja) アミド誘導体の製造方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 4

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

R14 Transfer of ownership recorded

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R14-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)